1Brener Z Z,Kotanko P,Thijssen S,et al.Clinical benefit of preserving residual renal function in dialysis patients:an update for clinicians[J].Am J Med Sci,2010,339(5):453-456.
2Wang AY,Lam C W,Wang M,et al.Circulating soluble vascular cell adhesion molecule 1:relationships with residual renal function,cardiac hypertrophy,and outcome of peritoneal dialysis patients[J].Am J Kidney Dis,2005,45(4):715-729.
3Brener Z Z,Thijssen S,Kotanko P,et al.The Impact of Residual Renal Function on Hospitalization and Mortality in Incident Hemodialysis Patients[J].Blood Purif,2011,31 (4):243-251.
4Bobulescu IA.Renal lipid metabolism and lipotoxicity[J].Curr Opin Nephrol Hypertens,2010,19(4):393-402.
5Moist L M,Port F K,Orzol,S M,et al.Predictors of loss of residual renal function among new dialysis patients[J].J Am Soc Nephrol,2000,11(3):556-564.
7Mathew S,Tustison K S,Sugatani T,et al.The mechanism of phosphorus as a cardiovascular risk factor in CKD[J].J Am Soc Nephrol,2008,19(6):1092-1105.
8Onufrak S J,Bellasi A,Shaw LJ,et al.Phosphorus levels are associated with subclinical atherosclerosis in the general population[J].Atherosclerosis,2008,199(2):424-431.
9Naves-Diaz M,Passlick-Deetjen J,Guinsburg A,et al.Calcium,phosphorus,PTH and death rates in a large sample of dialysis patients from Latin America.The CORES Study[J].Nephrol Dial Transplant,2010,25(5):304-314.
10Taniguchi M.CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder).The impact of CKD-MBD on mortality[J].Clin Calcium,2010,20(7):1078-1087.
3Suda T,Hiroshige K,Ohta T,et al. The contributiaon of resklual renal function to overall nutritional status in chronic haemodialy sis patients[J]. Nephrol Dial Transplant, 2000,15 (3) : 396.
4Wong JK Sadtes DJ, McCarthy Met al. Analysis of early Failure tunneled hemedialysis catheter[J]. AJR, 2002,179 : 357.
5Tariq Shaft, MBBS, MHS, et al. Association of Residual Urine Output with Mortality, Quality of Life,and Inflammation in Inci dent Hemodialysis Patients=The CHOICE (Choices for Healthy Outcomes in Caring for End Stage Renal Disease) Study[J]. Am J Kidney Dis,2010,56(2) =348.
6Qiongqiong Y, Ruixi L. et al. Is cystatin C a better marker than ereatinine for evaluating residual renal function in patients on continuous ambulatory peritoneal dialysis [J]. Nephrol Dial Transplant, 2011,26 : 3358.
